ORGANIC
LETTERS
2000
Vol. 2, No. 12
1705-1708
Solution-Phase Synthesis of Diaryl
Selenides Using Polymer-Supported
Borohydride
Corinne Millois and Philippe Diaz*
GALDERMA R&D, 635 route des Lucioles BP87, F06902
Sophia-Antipolis Cedex, France
Received March 15, 2000
ABSTRACT
A new series of selenium-containing diaryl retinoids have been prepared by a new direct nickel(II)-catalyzed coupling of a diselenide with an
iodoaryl in the presence of polymer-supported borohydride.
Retinoids (Figure 1), synthetic1 and natural analogues of all-
trans or 9-cis-retinoic acid, exert profound effects on cell
differentiation and proliferation.2 These biological properties
are indicative of a high potential for the treatment of
hyperproliferative disorders such as psoriasis or cancer. Many
of their biological effects are mediated by activation of
nuclear receptors. There are two known types of retinoic acid
receptors, RAR (R, â, and γ)3 and RXR (R, â, and γ),4
located in the cell nucleus. In the presence of ligand, these
receptors form dimers which bind to DNA through distinct
response elements.
reported the synthesis of a new series of selenium-containing
retinoids7 (CD3386) with potent RAR affinities. In regard
to the similarities between sulfur and selenium (structural,
potentially oxidable ...), we decided to synthesize a new series
of diarylselenium-containing RXR compounds.
A variety of synthetic routes to unsymmetrical diaryl
selenides have been described.8 Among them, the nickel-
(II)-catalyzed substitution of aryl halides by aryl selenolates9
is compatible with many functional groups. The method used
requires previous preparation of the anion from the corre-
sponding diselenide using sodium borohydride. We were
troubled with the foul smell of byproducts and by the rapid
conversion of the anion to the corresponding diselenide in
the presence of air. On the other hand, it has been shown
Others5 and us6 were interested in the synthesis of RXRs
selective diaryl sulfide compounds (CD2809). Recently we
(1) (a) Charpentier, B.; Bernardon, J. M.; Eustache, J.; Millois, C.; Martin,
C.; Michel, S; Shroot, B. J. Med. Chem. 1995, 38, 4993-5006. (b) Diaz,
P.; Michel, S.; Stella, L.; Charpentier, B. Bioorg. Med. Chem. Lett. 1997,
7, 2289-2294. (c) Diaz, P.; Gendre, F.; Stella, L.; Charpentier, B.
Tetrahedron 1998, 54, 4579-4590.
(5) Beard R. L.; Colon D. F.; Song T. K.; Davies P. J. A.; Kochhar D.
M.; Chandraratna R. A. S., J. Med. Chem. 1996, 39, 3556-1563.
(6) Bernardon J. M., C.I.R.D. GALDERMA, EP 0679630-A1, 1995;
Chem. Abstr. 1996, 124, 145647e.
(7) Diaz, P.; Gendre, F.; Bernardon, J. M. Tetrahedron Lett. 1998, 39,
9003-9006.
(8) (a) Pierini, A. B.; Rossi, R. A. J. Org. Chem. 1979, 44, 4667-4673.
(b) Gassman, P. G.; Miura, A.; Miura, T. J. Org. Chem. 1982, 47, 951-
954. (c) Osuka, A.; Ohmasa, N.; Susuki, H., Synthesis 1982, 857-858. (d)
Sindelar, K.; Svatek, E.; Metysova, J.; Metys, J.; Provita, M. Collect. Czech.
Chem. Commun. 1969, 34, 3792-3800.
(9) Cristau, H. J.; Chabaud, B.; Labaudiniere, R.; Christol, H. Organo-
metallics 1985, 4, 657-661.
(2) Sporn, M.; Roberts, A. B.; Goodman, D. S. In The Retinoids: Biology,
Chemistry, and Medecine; Raven Press: New York, 1994.
(3) (a) Guiguere, V.; Ong, E. S.; Segui, P.; Evans, R. M. Nature 1987,
330, 624-629. (b) Brand, N.; Petkovitch, M.; Krust, A.; Chambon, P.; de
The´, H.; Marchio, A.; Tiollais, P.; Dejean, A. Nature 1988, 332, 850-853.
(c) Krust, A.; Kastner, P.; Petkovitch, M.; Zelent, A.; Chambon, P. Proc.
Natl. Acad. Sci. U.S.A. 1989, 86, 5310-5314.
(4) (a) Mangelsdorf, D.; Ong, E.; Dyck, J.; Evans, R. Nature 1990, 345,
224-229. (b) Mangelsdorf, D.; Borgmeyer, U.; Heyman, R.; Zhou, J.; Ong,
E.; Oro, A.; Kakizuka, A.; Evans, R. Genes DeV. 1992, 6, 329-344.
10.1021/ol0058184 CCC: $19.00 © 2000 American Chemical Society
Published on Web 05/23/2000